Cargando…
Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein
The fusion glycoprotein (F) is essential for respiratory syncytial virus (RSV) entry and has become an attractive target for anti-RSV drug development. Despite the promising prospect of RSV F inhibitors, issues of drug resistance remain challenging. In this study, we established a dual-luciferase pr...
Autores principales: | Tang, Wei, Li, Yueyue, Song, Qiaoyun, Wang, Ziqin, Li, Manmei, Zhang, Qiwei, Wang, Ying, Ye, Wencai, Li, Yaolan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475503/ https://www.ncbi.nlm.nih.gov/pubmed/34379500 http://dx.doi.org/10.1128/JVI.01205-21 |
Ejemplares similares
-
Respiratory Syncytial Virus Infection Does Not Induce Epithelial-Mesenchymal Transition
por: Talukdar, Sattya N., et al.
Publicado: (2023) -
Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity
por: Liang, Wenzhang, et al.
Publicado: (2021) -
Activation of the Chemokine Receptor CCR1 and Preferential Recruitment of Gαi Suppress RSV Replication: Implications for Developing Novel Respiratory Syncytial Virus Treatment Strategies
por: Li, Jiao, et al.
Publicado: (2022) -
In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants
por: van Erp, Elisabeth A., et al.
Publicado: (2017) -
An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25
por: Van Royen, Tessa, et al.
Publicado: (2022)